SYM-1219

DRUG3 trials

Sponsors

Symbiomix Therapeutics

Conditions

Bacterial Vaginosis

Phase 2

A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis

CompletedNCT02147899

Symbiomix TherapeuticsBacterial Vaginosis

Start: 2014-05-31End: 2014-10-31Updated: 2020-11-13

Phase 3

A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis

CompletedNCT02418845

Symbiomix TherapeuticsBacterial Vaginosis

Start: 2015-05-28End: 2015-12-05Updated: 2021-10-15

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

CompletedNCT02452866

Symbiomix TherapeuticsBacterial Vaginosis

Start: 2015-06-30End: 2015-10-31Updated: 2021-04-13

Related Papers

Secnidazole Treatment of Bacterial Vaginosis

Obstetrics and Gynecology2017-07-1133 citations